ARCHIVES

Zevalin Regimen Better Than Rituximab Alone For NHL

This article is from The Cancer Letter archive.

Vol. 24 No. 6 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention

November 16, 1979

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

NCI CTEP Approved Trials For the Month of February

February 22, 2013

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

In Brief: Issell To Retire As Hawaii Center Director; M.D. Anderson honors LeMaistre, Faculty

November 8, 1996

Clinical Trials Approved By NCI During November Are Listed

December 27, 2002